We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ZeptoMetrix an Antylia scientific company

Download Mobile App




Circulating Exosomes Analysis Uses Microfluidic Technology

By LabMedica International staff writers
Posted on 23 Oct 2014
A new microfluidic approach has been developed to streamline and expedite the exosome analysis pipeline by integrating specific immunoisolation and targeted protein analysis of circulating exosomes.

Tumor-derived exosomes have attracted increasing interest in non-invasive cancer diagnosis and monitoring of treatment response which will help in developing blood-based tests for disease diagnosis, especially when biopsy is difficult, costly, and sometimes not even an option.

Scientists and bioengineers at the University of Kansas Medical Center (Kansas City, KS, USA) devised an approach that enables selective subpopulation isolation and quantitative detection of surface and intravesicular biomarkers. More...
This can be done directly from a minimally invasive amount of plasma samples, within about 100 minutes with markedly improved detection sensitivity. The microfluidic technology uses a magnetic bead-based strategy to integrate and streamline the multi-step analysis of exosomes directly from human plasma. Compared to the surface-based exosome microchips the immunomagnetic method allows for enrichment of captured exosomes and convenient sample preparation for transmission electron microscopy (TEM) characterization in addition to higher capture efficiency and analysis sensitivity due to the larger surface area.

The scientists applied the technology to analyze clinical plasma specimens, mainly from non-small-cell lung cancer (NSCLC) patients. The prototype lab-on-a-chip is made of a widely used silicone rubber called polydimethylsiloxane and uses a technique called "on-chip immunoisolation”. To demonstrate the ability to detect exosomal expression patterns associated with cancer, the team conducted relative quantification of five exosome subpopulations defined by individual surface markers using TEM. They optimized the on-chip bead-based immunoassay and chemifluorescence readout using a matched pair of capture/detection antibodies, an alkaline phosphatase (AP)-conjugated secondary antibody, and the 6,8-Difluoro-7-Hydroxy-4-Methylcoumarin (DiFMUP) substrate.

Yong Zeng, PhD, a co-author of the study, said, “Our technique provides a general platform to detecting tumor-derived exosomes for cancer diagnosis. In addition to lung cancer, we've also tested for ovarian cancer in this work. In theory, it should be applicable to other types of cancer. Our long-term goal is to translate this technology into clinical investigation of the pathological implication of exosomes in tumor development. Such knowledge would help develop better predictive biomarkers and more efficient targeted therapy to improve the clinical outcome.” The study was published in the October 2014 issue of the journal Lab on a Chip.

Related Links:

University of Kansas Medical Center



Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Cytomegalovirus Test
NovaLisa Cytomegalovirus (CMV) IgG Test
New
Chagas Disease Test
LIAISON Chagas
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: The GlycoLocate platform uses multi-omics and advanced computational biology algorithms to diagnose early-stage cancers (Photo courtesy of AOA Dx)

AI-Powered Blood Test Accurately Detects Ovarian Cancer

Ovarian cancer ranks as the fifth leading cause of cancer-related deaths in women, largely due to late-stage diagnoses. Although over 90% of women exhibit symptoms in Stage I, only 20% are diagnosed in... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Pathology

view channel
Image: AI-analyzed images from the FDM microscope show platelet clumps in motion (Photo courtesy of Hirose et al CC-BY-ND)

AI Microscope Spots Deadly Blood Clots Before They Strike

Platelets are small blood cells that act as emergency responders in the body, rushing to areas of injury to help stop bleeding by forming clots. However, sometimes platelets can overreact, leading to complications.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.